<DOC>
	<DOCNO>NCT01471236</DOCNO>
	<brief_summary>The purpose study determine performance Agili-C implant . The study hypothesis Agili-C implant effective treatment focal cartilage cartilage-bone joint surface defect .</brief_summary>
	<brief_title>Evaluation Agili-C Biphasic Implant Knee Joint</brief_title>
	<detailed_description>Agili-C implant bi-phasic , porous resorbable tissue regeneration scaffold treatment focal articular cartilage osteochondral defect . Up 50 patient include study . Patients suffer isolated , single focal cartilage osteochondral defect knee joint consider study inclusion .</detailed_description>
	<mesh_term>Osteochondritis</mesh_term>
	<mesh_term>Osteochondritis Dissecans</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Inclusion Criteria 1 . 18 55 year 2 . Symptomatic , single , focal , full near fullthickness ( ICRS cartilage defect description grade 3 4 ) chondral osteochondral isolate lesion femoral condyle , trochlea tibial plateau Defect area le 2 cm² debridement . The defect completely surround side healthy cartilage . Osteochondral defect ICRS Cartilage defect description type 1 , 2 , 3 , 4A . Maximal defect depth 3 millimeter . 3 . Primary secondary articular cartilage repair . 4 . Knee stable stabilize concomitant procedure . 5 . Must physically mentally willing able comply postoperative rehabilitation routinely schedule clinical radiographic visit . 6 . Signed informed consent . 7 . Any misalignment fully correct end operative procedure . Exclusion Criteria 1 . Uncorrected axial misalignment &gt; 5° correct . 2 . Patellar cartilage defect pathology . 3 . Meniscal resection 50 % , either previous procedure concomitant articular cartilage repair . 4 . Any tumor ipsilateral knee , concurrent malignant tumor metastatic tumor past present . 5 . Active acute chronic infection treat knee . 6 . Inflammatory arthropathy crystaldeposition arthropathy . 7 . Systemic cartilage and/or bone disorder ; This implant integration dependent surround live bleeding bone ; therefore must implant within sequestrate necrotic bone . 8 . Bony defect depth 3 millimeter . 9 . Body mass index &gt; 35 . 10 . Asymptomatic articular cartilage defect . 11 . Bipolar articular cartilage defect . 12 . Osteoarthritis operate knee . 13 . Oral medication systemic corticosteroid therapy take less one year prior surgery chemotherapy . Previous operative treatment Arthroscopic marrow stimulation technique cell therapy operate within last 6 month Any previous operation cartilage treatment within last 6 month 14 . Patients sensitive material contain calcium carbonate hyaluronate 15 . Pregnant woman , woman plan become pregnant breastfeeding woman . 16 . Evidence significant systemic disease ( limited HIV infection , hepatitis infection HTLV infection ) , know coagulopathies , severe vascular neurological disease acute injury might compromise patient 's welfare . 17 . Substance abuse alcohol abuse . 18 . Participation another clinical trial parallel study . 19 . Type I diabetes . 20 . Unable undergo MRI Xray . 21 . Any reason make patient poor candidate opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>cartilage</keyword>
	<keyword>bone</keyword>
</DOC>